Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions.
about
A lectin isolated from bananas is a potent inhibitor of HIV replicationThe tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virusMechanisms and therapeutic effectiveness of lactobacilliThe hepatitis C virus glycan shield and evasion of the humoral immune responseCarbohydrate-Binding Non-Peptidic Pradimicins for the Treatment of Acute Sleeping Sickness in Murine ModelsMultivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors.Sugar-Binding Profiles of Chitin-Binding Lectins from the Hevein Family: A Comprehensive StudyBroad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cellsRole of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions.Characterization and carbohydrate specificity of pradimicin S.Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV Type 1, HIV Type 2, and selected carbohydrate-binding agent-resistant HIV Type 1 strainsA phenyl-thiadiazolylidene-amine derivative ejects zinc from retroviral nucleocapsid zinc fingers and inactivates HIV virions.Hepatitis C Virus Resistance to Carbohydrate-Binding AgentsInhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA.Potential of carbohydrate-binding agents as therapeutics against enveloped viruses.Bitter-sweet symphony: glycan-lectin interactions in virus biology.HIV-1 and its resistance to peptidic carbohydrate-binding agents (CBAs): an overview.Human lectins and their roles in viral infections.Antiviral activity of recombinant porcine surfactant protein A against porcine reproductive and respiratory syndrome virus in vitro.Glycosylation of dengue virus glycoproteins and their interactions with carbohydrate receptors: possible targets for antiviral therapy.Intracytoplasmic trapping of influenza virus by a lipophilic derivative of aglycoristocetin.NICTABA and UDA, two GlcNAc-binding lectins with unique antiviral activity profiles.Expression analysis of the nucleocytoplasmic lectin 'Orysata' from rice in Pichia pastoris.Lectin microarray and mass spectrometric analysis of hepatitis C proteins reveals N-linked glycosylation.Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies.Lectins as Promising Therapeutics for the Prevention and Treatment of HIV and Other Potential Coinfections.Protein glycosylation in infectious disease pathobiology and treatmentPathobiology of virus glycosylation: implications to disease and prospects for treatmentBlocking HCV entry as potential antiviral therapyCarbohydrates on HIV: mediators of immune evasion and targets for antiviral intervention
P2860
Q24629155-0BD55853-F338-46EE-A880-4A2C841FF0CFQ24652906-9CF12B86-17EE-4289-A274-F56CE3E109D6Q27012999-F2125753-F67B-448A-B395-BE3E5ED43854Q27023390-2A6BE317-F5BA-43E1-B739-E41A5175F7C7Q27312132-853CA53C-8023-446D-8A12-862C042BD700Q33625151-231DE8E0-9E38-4718-908D-3E9A2E0B5E39Q33838566-00B36992-1E92-44BC-B739-6777582162C6Q33955239-F46488E7-7370-42D1-8CD2-04B7A2805829Q34295953-74611842-F556-43E1-BDA2-A8B59922206BQ34334328-FEB83F44-3E0E-4301-BDAE-0A24D0D723FAQ36358780-38DB0973-31A9-4BCF-B68E-148DF87AA955Q36523852-24D29C19-6796-49A1-9CD2-60660768CB56Q36576382-032F5C47-C3F4-4EE2-98D4-1586900EC25CQ37533386-E623ABA9-57AF-45DB-9E9A-98DC4042AF65Q37767654-00E11346-BA01-4D7F-B942-60E111826FE6Q38159719-2B7CCB7F-3322-4FE8-A759-2D3C07655974Q38291704-F4397199-8CBC-416D-B752-1BA340980E72Q38340871-6B0896FB-14F2-4918-8F68-4AA102310AC0Q38776537-105D13FB-0768-41A7-AD1E-1CCD31168C3AQ38805480-901F7FD4-70FA-4B1A-A581-8D86D6B3B83CQ39323887-872F8E48-56AB-4585-80A3-D5755AA839A6Q40168596-A7217E65-9075-40BE-8B8E-E3AB3A57E3D4Q49066063-EFFF9B2B-1A63-4285-86DE-EE480D09C763Q52593865-CECFD2D9-8CBF-4BB3-9B16-2DFEF6264510Q53683152-260C0AD3-BDD3-47B1-8032-18634E77CB92Q55120164-D67A8D97-D936-45A0-B3A1-B9AC887DF4BEQ57202107-343E83A8-E749-402A-AEF7-332C82D398C1Q57202110-F6CFB74D-C2A4-40C5-BBF0-17D207B0241EQ57241788-48DA1162-FDBF-4DDE-BAE7-FD120368385AQ57252416-06BD0A3D-49AC-4F3C-B7B6-1C91E7C46834
P2860
Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Entry of hepatitis C virus and ...... agents but not by polyanions.
@ast
Entry of hepatitis C virus and ...... agents but not by polyanions.
@en
Entry of hepatitis C virus and ...... agents but not by polyanions.
@nl
type
label
Entry of hepatitis C virus and ...... agents but not by polyanions.
@ast
Entry of hepatitis C virus and ...... agents but not by polyanions.
@en
Entry of hepatitis C virus and ...... agents but not by polyanions.
@nl
prefLabel
Entry of hepatitis C virus and ...... agents but not by polyanions.
@ast
Entry of hepatitis C virus and ...... agents but not by polyanions.
@en
Entry of hepatitis C virus and ...... agents but not by polyanions.
@nl
P2093
P50
P1433
P1476
Entry of hepatitis C virus and ...... agents but not by polyanions.
@en
P2093
Claire Bertaux
Els J M Van Damme
Emmanuel G Cormier
John F Reinus
Laurent Meertens
Tatjana Dragic
Toshikazu Oki
Willy J Peumans
Yasuhiro Igarashi
P356
10.1016/J.VIROL.2007.04.008
P407
P577
2007-05-11T00:00:00Z